Clinical trial
Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
NCT00453271 · NanoBio Corporation, Industry · Completed
Key facts
| NCT number | NCT00453271 |
|---|---|
| Title | Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail |
| Official title | A Randomized, Double-Blind, Parallel-Group,Multicenter, Dose-Response, Vehicle-Controlled Study of the Safety and Efficacy of NB-002 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail |
| Lead sponsor | NanoBio Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Onychomycosis |
| Intervention type | Drug |
| Interventions | NB-002, Vehicle control |
| Enrollment | 443 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 28, 2007 |
| Last update posted | May 23, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: